Borregaard ASA: EBITDA1 of NOK 398 million in the 4th quarter

Financial Performance - Operating revenues in Q4 2024 were NOK 1,744 million, up from NOK 1,605 million in the same period last year [1] - EBITDA in Q4 2024 reached NOK 398 million, compared to NOK 327 million in Q4 2023 [1] - Profit before tax in Q4 2024 was NOK 170 million, up from NOK 135 million in Q4 2023 [3] - Earnings per share in Q4 2024 were NOK 1.30, compared to NOK 1.20 in Q4 2023 [3] - Full-year 2024 operating revenues increased to NOK 7,617 million from NOK 7,132 million in 2023 [4] - Full-year 2024 EBITDA reached an all-time high of NOK 1,874 million, up from NOK 1,781 million in 2023 [4] - Full-year 2024 profit before tax was NOK 1,079 million, compared to NOK 1,124 million in 2023 [4] - Full-year 2024 earnings per share were NOK 8.25, down from NOK 8.73 in 2023 [4] Segment Performance - BioSolutions segment showed increased results compared to Q4 2023 [1] - BioMaterials segment remained at the same level as Q4 2023 [1] - Fine Chemicals segment experienced a decrease in results compared to Q4 2023 [1] - Increased sales were the main driver for the strong performance in BioSolutions [2] - Higher sales volume and improved product mix of specialty cellulose in BioMaterials were offset by increased wood costs [2] - Lower deliveries were the primary reason for the weaker performance in Fine Chemicals [2] Other Financial Information - Net currency effects were positive in Q4 2024 [2] - Other income and expenses in Q4 2024 were NOK -30 million, related to remediation of contaminated soil at the Sarpsborg site [2] Management Commentary - The company reported an all-time high result for 2024 [4] - The company's specialization strategy has proven resilient amid challenging macroeconomic and geopolitical conditions [4]